Detalles de la búsqueda
1.
Valuing injection frequency and other attributes of type 2 diabetes treatments in Australia: a discrete choice experiment.
BMC Health Serv Res
; 18(1): 675, 2018 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-30165844
2.
Beyond needs and expectations: identifying the barriers and facilitators to written medicine information provision and use in Australia.
Health Expect
; 17(2): 220-31, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22390211
3.
Enhancing provision of written medicine information in Australia: pharmacist, general practitioner and consumer perceptions of the barriers and facilitators.
BMC Health Serv Res
; 14: 183, 2014 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-24754890
4.
Consumer Opinions on Existing and Proposed Australian Over-the-Counter Medicine Labeling Strategies in Comparison With the Standardized US Drug Facts Label.
Ther Innov Regul Sci
; 50(4): 427-435, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30227019
5.
Respiratory diseases and the impact of cough in Taiwan: Results from the APBORD observational study.
Medicine (Baltimore)
; 95(27): e3854, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27399064
6.
The burden of segregated respiratory diseases in India and the quality of care in these patients: Results from the Asia-Pacific Burden of Respiratory Diseases study.
Lung India
; 33(6): 611-619, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27890989
7.
Pharmacist, general practitioner and consumer use of written medicine information in Australia: are they on the same page?
Res Social Adm Pharm
; 10(4): 656-68, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24239213
8.
Pharmacist and general practitioner ambivalence about providing written medicine information to patients-a qualitative study.
Res Social Adm Pharm
; 9(5): 517-30, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23567071
Resultados
1 -
8
de 8
1
Próxima >
>>